In this podcast, we hear from Euretina Keynote Bertil Damato (UK/Sweden) about his upcoming talk on OncoVR at the 2023 Euretina Congress. He is joined by colleague Carl Groenewald (UK) and Heinrich Heimann (Chair - UK)
In this podcast, we'll be hearing about an exciting new event taking place in Amsterdam at the Euretina Congress in October; the inaugural Euretina Innovation Summit (EIS). Kourous Rezaei (USA) and Anat Loewenstein (Israel) - two members of the organising committee - will discuss the programme and motivation behind the event with chair Frank G Holz (Germany)
In this podcast, we’ll explore two areas in the subspecialty of myopia: Aude Couturier will share her expertise in macular holes and Dr Yves Lachkar will discuss glaucoma in highly myopic patients. Chaired by David Gaucher and Jost Jonas
In this episode, Editor in Chief at Ophthalmologica, Professor Martin Zinkernagel discusses two featured papers from Euretina’s official journal. The first paper discussed covers choroiditis and the second covers effective treatment regimen in macular degeneration. Faculty are Dr Jeannette Ossewaarde-van Norel and Evianne de Groot (University Medical Center Utrecht) and Mathis Thibaud, Red Cross University Hospital, Lyon
In this episode, we explore how to diagnose and treat intraocular lymphoma with a panel of leading retinal surgeons and oncologists. Dr Hibba Quhill chairs the discussion with Professors Carlos Pavesio and Mandeep Sagoo from Moorfields Eye Hospital, London.
In this episode, we will hear all of the tips and tricks to success when looking to submit your research to Ophthalmologica. Faculty: Martin Zinkernagel (Ophthalmologica editors) and Marco Casola (Karger). Chaired by Jonathan McCrea
In this episode, Edoardo Midena (Italy) chairs a discussion with four leading experts in Diabetic Retinopathy from across the world: Jakob Grauslund (Denmark), Carol Cheung (Hong Kong), Enrico Borrelli (Italy) and Daniel Ting (Singapore)
In this episode, Siegfried Priglinger (Germany) and Roxane Hillier (UK) take a look at treatment for macula-off RRD. They're joined by David Yorston (Scotland) and Julian Klaas (Germany) and will ask - how do we best define "macula-off" and when should we start treatment?
Treating rare diseases can sometimes be challenging due a the lack of literature. In this episode, Carlos Pavesio (UK) asks leading experts Sara Touhami (France) and Moncef Khairallah (Tunisia) about their approaches to the diagnosis and treatment of Acute Retinal Necrosis (ARN).
In this podcast, David Steel tells Alistair Laidlaw what he's learned from zeroing in on individual patient data and how factors like posture and hole size affect his decision-making in the treatment of macular holes
In this podcast, Mark Penessi is joined by Isabelle Audo and Bart Leroy to discuss the impact of Luxturna and how gene therapy products will affect the treatment of inherited retinal diseases (IRD) in the future.
In this episode, Euretina President Alistair Laidlaw chairs a discussion with Nicole Eter (München University Medical Centre) and Brendan Strong, Head of Education at Agenda about the new EBO examination.
In this podcast, we hear from author and leadership coach Sally Helgesen, author of Why Women Rise about the challenges facing aspiring women leaders. The interview is followed by a discussion with Prof Anat Loewenstein (Israel) and Dr Ruth Freeman (Science Foundation Ireland) about the Women in Retina programme and how to move the dial when it comes to equality of opportunity in medical research. Guests: Sally Helgesen (Author, USA) Prof Anat Loewenstein (Israel) and Dr Ruth Freeman (Science Fo...
In this in-depth podcast, Euretina President-Elect Ramin Tadayoni (France) chairs a discussion with Kyoko Ohno Matsui (Japan) and David Gaucher (France) exploring everything you need to know when dealing with the “bad guy” in myopia - Staphyloma. Panel: Prof Ramin Tadayoni, University Of Paris Cite, Lariboisière, Saint Louis And Adolphe De Rothschild Foundation Hospitals, France Kyoko Ohno Matsui Tokyo Medical And Dental University, Japan David Gaucher Dept Of Ophthalmology, University Of Strasb...
In this episode, Hibba Quhill (UK) explores each of the components that make up the MOLES system used for management of melanocytic choroidal tumours with the system's originator, Bertil Damato (UK/Sweden).
In this episode we will look at the Derby and Oaks trials; two trials looking at geographic atrophy associated with AMD. The session is chaired by Professor Frank Holz (Germany), featuring Professors Adnan Tufail (UK) and Sandrine Zweifel (Switzerland).
Worried you missed out on some great content at EURETINA? Don't worry! In this episode, we look back on the best Euretina sessions from the Congress. Joining us to give us their highlights from Hamburg are: Alistair Laidlaw, Euretina President, Ramin Tadayoni (France) and Kourous Rezaei (USA)
In this episode, we catch up with Professors Camiel Boon, Tunde Peto and Dr Patricia Udaondo (New University and Polytechnic Hospital La Fe, Valencia) fresh from an incredible event in Hamburg to hear all about their highlights of the congress. They'll share their standout sessions that you need to catch up on via the Euretina portal at www.euretina.org Euretina 2022 Hamburg highlights: Tunde Peto: Euretina Lecture - Sobha Sivaprasad Euretina Session 10: Inherited Retinal Diseases Subspecialty S...
In this episode, we will again hear from two of our keynote speakers at the Euretina congress in Hamburg this September. Prof Hiroko Terasaki (Japan) who will give the Kreissig Lecture on Sept 3rd at Euretina (interviewed by Professor Ramin Tadayoni, Euretina President Elect) and Dr Enrico Borrelli (Italy) who will give the Ophthalmologica lecture (interviewed by Prof Frank Holz, Bonn, former Euretina President).
In this episode Euretina President Mr Alistair Laidlaw previews two of our keynote speakers from this year's Euretina Congress in Hamburg. He is joined by Professor Sobha Sivaprasad (UK) and Professor Catherine Creuzot-Garcher (France)
Talking Euretina is taking a short break but will be back in August
In this episode, we explore non-invasive imaging of retinal diseases in a discussion chaired by Dr Stela Vujosevic ( Italy). Our faculty are Dr Bianca Gerendas, Medical University of Vienna and Dr Amani Fawzi, Northwestern University of Chicago.
In this episode, we return to the topic of ocular oncology to explore choroidal naevi in daily practice, through Imaging, follow-ups and the MOLES system. This expert discussion is chaired by Heinrich Heimann who is joined by Prof Bertil Damato, Dr Rumana Hussain, Dr Iwona Rospond-Kubiak and Dr Jose Caminal.
This Journal Club is all about subretinal hemorrhaging as we take a look at 2 relevant papers and hear the latest developments of the Euretina-sponsored TIGER Study. It is chaired by Professors Grazia Pertile (Sacro Cuore Hospital Negrar, Verona) and Siegfried Priglinger (LMU Munich). They're joined by Professor Timothy Jackson (King’s College, London), Dr Emilia Maggio (Sacro Cuore Hospital Negrar, Verona) and Dr Saskia van Romunde (The Rotterdam Eye Hospital)
In this episode, Professor Sandrine Zweifel (Switzerland) and Professor Adnan Tufail (UK) chair a discussion on how imaging has affected our understanding of AMD. They discuss the impact of new biomarkers and also explore the effect of big data on this field now and into the future. Contributing faculty are Professor Christine Curcio (USA), Professor K Bailey Freund (USA) and Professor Srinivas Sadda (USA).
In this episode, Carlos Pavesio (UK) and Sofia Androudi (Greece) share their experience and insights in the diagnosis and treatment of macular edema. Chaired by Bahram Bodaghi (France).
In this episode, we hear from Brent Dykes about the importance of storytelling with data and how to implement it when communicating research. Brent is author of Effective Data Storytelling, founder of Analytics Hero and a regular contributor to Forbes.
In this episode, we explore the benefits of the Euretina Mentorship Programme. Guests are programme mentor and Euretina Board member, Dr Patricia Udaondo and Dara Conlon, Euretina Executive Vice President.
In January, The Lancet journal published studies showing that across 4 trials, faricimab improved and maintained vision in two leading causes of vision loss and reduced time between treatments. In this episode, we examine the results and implications of the research in an expert discussion chaired by Prof Anat Loewenstein (Tel Aviv Medical Centre) and Prof Reinier Schlingemann (Amsterdam University and Jules Gonin). They are joined by Ramin Tadayoni (Paris University), Professor Sandrine Zweifel...
In this episode, Professors Heinrich Heimann (Liverpool University Hospital) and Jens Kiilgaard (Copenhagen University Hospital) chair a conversation about metastatic disease in uveal melanoma and a newly approved treatment, Tebentafusp. They’re joined by Dr Joseph Sacco (Liverpool University Hospital) and Dr Mette Bagger (Copenhagen University Hospital)
